RESMED INC — Director's Dealing 2016

Jan 5, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-01-04

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-04	ResMed Common Stock	M	6000	$33.70	Acquired	80287	Direct
2016-01-04	ResMed Common Stock	S	6000	$52.16	Disposed	74287	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-04	ResMed Common Stock Options	$33.700	M	6000	Disposed	2017-11-11	ResMed Common Stock (6000)	Direct

Footnotes

F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable. Options vest 1/4 per year on the anniversary of the grant.

F3: This transaction was executed in multiple trades at prices ranging from $52.076 to $52.23. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.